With 25+ years in life sciences, USDM transforms ServiceNow into a unified platform for GxP and non-GxP workflows. Powered by ProcessX, we align technology, quality, and regulatory requirements to reduce compliance costs, accelerate deployment, and maintain continuous audit readiness.
• GxP-VALIDATED WORKFLOWS ON SERVICENOW
Run GxP Workflows on ServiceNow — Without Custom Builds or Revalidation
ProcessX transforms ServiceNow into a validated, Part 11–ready platform for life sciences in as little as 6–12 weeks.
No second instance. No custom Part 11 development. No ongoing validation burden.
Built for CIOs and IT Quality Leaders Who Need
- A single enterprise ServiceNow platform
- Audit-ready GxP workflows
- Predictable validation overhead
The Strategic Question for CIOs
Most life sciences companies implementing ServiceNow eventually face the same decision:
How do we support GxP processes on the platform?
There are three common approaches.
| Approach | Timeline | Cost | Risk |
|---|---|---|---|
|
Custom Development on ServiceNow |
6–18 months |
$300K–$600K+ |
High |
|
Separate GxP ServiceNow Instance |
9–18 months |
$400K–$800K+ |
Depends on architecture complexity |
|
ProcessX |
6–12 weeks |
$200K–$350K |
Low |
For most organizations, the decision comes down to speed, risk, and operational overhead.
30 minutes. No pitch deck. We'll assess your GxP readiness on ServiceNow and show you quick wins.
The Hidden Operational Problems
The Ongoing Validation Burden of ServiceNow
The biggest challenge isn’t the initial validation. It’s maintaining compliance through every platform upgrade.
ServiceNow releases:
- Monthly patches
- Two major upgrades each year
For regulated environments, each release requires impact assessment, regression testing, and validation documentation.
Typical Annual Validation Effort
- 24–40 hours of validation for every monthly patch
- 160–240 hours for each platform upgrade
- Continuous documentation updates for custom code
This can total 608–960 hours of validation effort per year.
ProcessX eliminates most of this operational burden by managing the validation framework and upgrade testing.
Why a Second ServiceNow Instance Creates Problems
Many organizations attempt to isolate GxP workflows by creating a separate validated ServiceNow instance.
This creates significant operational challenges:
- Duplicate licensing costs
- Separate DEV / QA / UAT / PROD stacks
- Independent upgrade cycles
- Additional administration teams
Most critically, it breaks unified CMDB visibility across IT operations and quality.
Without a single configuration view, organizations lose the ability to understand service dependencies and change impact across the enterprise.
ProcessX enables physical data segregation within a single ServiceNow platform, allowing regulated and non-regulated processes to coexist safely.
What ProcessX Adds to ServiceNow
Trusted by regulated life sciences leaders
Executive Outcomes
Faster Digital Transformation – Deploying validated GxP workflows in weeks instead of years.
Reduced Validation Overhead – Eliminating hundreds of hours of annual upgrade validation.
Unified ServiceNow Architecture – Maintain one enterprise platform for IT and Quality.
Continuous Audit Readiness – Validation documentation and traceability are maintained automatically.
Arrowhead Pharmaceuticals
See what ProcessX can do for your regulated environment.
Book a 30-minute discovery call with a USDM life sciences specialist. No generic demo. We’ll discuss your ServiceNow environment, your GxP requirements, and where ProcessX can deliver fast, measurable impact.
Empowering Intelligent Automation with ServiceNow
This clip, from USDM’s 2026 Summit, explores how ServiceNow isn’t replacing Veeva, SAP, or Oracle—it’s connecting them. In this discussion, discover how life sciences companies can unify data across systems, apply regulated AI to predict risk, and orchestrate compliant workflows end to end.
If you’re looking to drive intelligent automation without disrupting your systems of record, this is a must-watch.